You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 3, March 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (150)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Alzheimer Disease
 •Behavioral Neurology
 •Cognitive Disorders
 •Dementias
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss

Andrea Bozoki, MD; Bruno Giordani, PhD; Judith L. Heidebrink, MD; Stanley Berent, PhD; Norman L. Foster, MD

Arch Neurol. 2001;58:411-416.

Background  Some elderly individuals exhibit significant memory deficits but do not have dementia because their general intellect is preserved and they have no impairments in everyday activities. These symptoms are often a precursor to Alzheimer disease (AD), but sometimes dementia does not occur, even after many years of observation. There is currently no reliable way to distinguish between these 2 possible outcomes in an individual patient. We hypothesized that clear impairments in at least 1 cognitive domain in addition to memory would help identify those who will progress to AD.

Objective  To determine whether nondemented patients with impairments in memory and other domains are more likely than those with memory impairment alone to develop AD.

Design and Methods  In a retrospective study, we evaluated 48 nondemented, nondepressed patients with clinical and psychometric evidence of memory impairment who were followed up for 2 or more years. Age-adjusted normative criteria were used to identify whether additional impairments were present in language, attention, motor visuospatial function, and verbal fluency at this initial evaluation. The presence or absence of dementia after 2 years and at the most recent neurological evaluation was compared in subjects with normal scores in all 4 of these cognitive areas apart from memory (M-) and those with impairment in 1 or more of these areas (M+). Outcomes were adjusted for age, intelligence at initial evaluation, and years of education.

Results  Of the 48 nondemented patients with memory loss, 17 met M- criteria, leaving 31 in the M+ group. Deficits in block design were the most frequent abnormality other than memory loss. At the 2-year follow-up, 1 M- subject (6%) had progressed to AD, whereas 15 (48%) of the M+ group had progressed to AD (P = .003). At the most recent follow-up (mean ± SD, 4.0 ± 2.0 years), 4 (24%) of the M- patients progressed to AD compared with 24 (77%) of the M+ patients (P<.001).

Conclusions  Among nondemented elderly patients, memory loss alone rarely progresses to dementia in the subsequent 2 years. However, the risk of dementia is significantly increased among patients with clear cognitive impairments beyond memory loss. Further study is needed to determine whether patients with impairments limited to memory loss have a distinctive clinical course or pathophysiology.


From the Departments of Neurology (Drs Bozoki, Heidebrink, and Foster) and Psychiatry (Drs Giordani and Berent), University of Michigan Medical Center, and Geriatric Research Education and Clinical Center, Ann Arbor Veterans Affairs Medical Center (Dr Heidebrink), Ann Arbor.

Corresponding author and reprints: Andrea Bozoki, MD, Department of Neurology, University of Michigan, TC1913A, 1500 E Medical Center Dr, Ann Arbor, MI 48109-0322 (e-mail: abozoki{at}med.umich.edu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts
Farias et al.
Arch Neurol 2009;66:1151-1157.
ABSTRACT | FULL TEXT  

Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis
Mitchell and Shiri-Feshki
J. Neurol. Neurosurg. Psychiatry 2008;79:1386-1391.
ABSTRACT | FULL TEXT  

Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt et al.
J Geriatr Psychiatry Neurol 2007;20:215-226.
ABSTRACT  

Predictors of progression from mild cognitive impairment to Alzheimer disease
Palmer et al.
Neurology 2007;68:1596-1602.
ABSTRACT | FULL TEXT  

Preclinical Vascular Cognitive Impairment and Alzheimer Disease: Neuropsychological Test Performance 5 Years Before Diagnosis
Ingles et al.
Stroke 2007;38:1148-1153.
ABSTRACT | FULL TEXT  

Spatial navigation deficit in amnestic mild cognitive impairment
Hort et al.
Proc. Natl. Acad. Sci. USA 2007;104:4042-4047.
ABSTRACT | FULL TEXT  

Word Reading and Posterior Temporal Dysfunction in Amnestic Mild Cognitive Impairment
Vandenbulcke et al.
Cereb Cortex 2007;17:542-551.
ABSTRACT | FULL TEXT  

Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment
Geroldi et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1219-1222.
ABSTRACT | FULL TEXT  

Telephone assessment of cognitive function in adulthood: the Brief Test of Adult Cognition by Telephone
Tun and Lachman
Age Ageing 2006;35:629-632.
FULL TEXT  

Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline
Boyle et al.
Neurology 2006;67:441-445.
ABSTRACT | FULL TEXT  

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
Tabert et al.
Arch Gen Psychiatry 2006;63:916-924.
ABSTRACT | FULL TEXT  

Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer's Disease
Marcos et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:189-196.
ABSTRACT  

Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen et al.
Arch Neurol 2006;63:665-672.
ABSTRACT | FULL TEXT  

Prodromal cognitive signs of dementia in 85-year-olds using four sources of information
Sacuiu et al.
Neurology 2005;65:1894-1900.
ABSTRACT | FULL TEXT  

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition
Nordlund et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1485-1490.
ABSTRACT | FULL TEXT  

Neuropsychological function in nondemented carriers of presenilin-1 mutations
Ringman et al.
Neurology 2005;65:552-558.
ABSTRACT | FULL TEXT  

The functional anatomy of divided attention in amnestic mild cognitive impairment
Dannhauser et al.
Brain 2005;128:1418-1427.
ABSTRACT | FULL TEXT  

Self-Administered Screening for Mild Cognitive Impairment: Initial Validation of a Computerized Test Battery
Tornatore et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:98-105.
ABSTRACT | FULL TEXT  

Mild cognitive impairment: a cross-national comparison
Arnaiz et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1275-1280.
ABSTRACT | FULL TEXT  

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia
DeCarli et al.
Neurology 2004;63:220-227.
ABSTRACT | FULL TEXT  

Dementia Assessment in Primary Care: Results From a Study in Three Managed Care Systems
Boise et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M621-M626.
ABSTRACT | FULL TEXT  

Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years
Logroscino et al.
BMJ 2004;328:548.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials
Grundman et al.
Arch Neurol 2004;61:59-66.
ABSTRACT | FULL TEXT  

Alzheimer's Disease: Neuropathologic Findings and Recent Advances in Imaging
Norfray and Provenzale
Am. J. Roentgenol. 2004;182:3-13.
FULL TEXT  

Platelet Amyloid Precursor Protein Abnormalities in Mild Cognitive Impairment Predict Conversion to Dementia of Alzheimer Type: A 2-Year Follow-up Study
Borroni et al.
Arch Neurol 2003;60:1740-1744.
ABSTRACT | FULL TEXT  

Variations in case definition affect prevalence but not outcomes of mild cognitive impairment
Fisk et al.
Neurology 2003;61:1179-1184.
ABSTRACT | FULL TEXT  

Mild cognitive impairment: Directions for future research
Luis et al.
Neurology 2003;61:438-444.
ABSTRACT | FULL TEXT  

Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria: Results of the Leipzig Longitudinal Study of the Aged (LEILA75+)
BUSSE et al.
Br. J. Psychiatry 2003;182:449-454.
ABSTRACT | FULL TEXT  

Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study
Palmer et al.
BMJ 2003;326:245-245.
ABSTRACT | FULL TEXT  

Mild cognitive impairment can be detected by multiple assessments in a single day
Darby et al.
Neurology 2002;59:1042-1046.
ABSTRACT | FULL TEXT  

Low Cognitive Performance, Comorbid Disease, and Task-Specific Disability: Findings From a Nationally Representative Survey
Blaum et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M523-531.
ABSTRACT | FULL TEXT  

Is Mild Cognitive Impairment Prodromal for Vascular Dementia Like Alzheimer's Disease?
Meyer et al.
Stroke 2002;33:1981-1985.
ABSTRACT | FULL TEXT  

Natural history of mild cognitive impairment in older persons
Bennett et al.
Neurology 2002;59:198-205.
ABSTRACT | FULL TEXT  

Alzheimer Disease as a Vascular Disorder: Nosological Evidence
de la Torre
Stroke 2002;33:1152-1162.
ABSTRACT | FULL TEXT  

Abnormalities in the Pattern of Platelet Amyloid Precursor Protein Forms in Patients With Mild Cognitive Impairment and Alzheimer Disease
Padovani et al.
Arch Neurol 2002;59:71-75.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.